{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:05:49Z","timestamp":1768547149972,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Perinatal transmission of HIV has dramatically decreased in high-income countries in the last few years with current rates below 1%, but it still occurs in high-risk situations, mainly pregnant women with late diagnosis of infection, poor antiretroviral adherence and a high viral load (VL). In these high-risk situations, many providers recommend combined neonatal prophylaxis (CNP). Our aim was to evaluate the safety and toxicity of CNP in infants deemed at high-risk of HIV infection among mother-infant pairs in the Madrid Cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>Prospective, multicenter, observational cohort study between years 2000 and 2019. The subgroup of newborns on CNP and their mothers were retrospectively selected (cohort A) and compared with those who received monotherapy with zidovudine (cohort B). Infants with monotherapy were classified according to treatment regimes in long (6 weeks) and short (4 weeks) course.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We identified 227 newborns (33.3% preterm and 7 sets of twins) with CNP. A maternal diagnosis of HIV-1 infection was established during the current pregnancy in 72 cases (36.4%) and intrapartum or postpartum in 31 cases (15.7%). Most infants received triple combination antiretroviral therapy (65.6%; n = 149). The perinatal transmission rate in cohort A was 3.5% (95% confidence interval: 1.13%\u20135.92%). Infants from cohort A developed anemia (26.1% vs. 19.4%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.14) and neutropenia more frequently at 50\u2013120 days (21.4% vs. 10.9%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01), without significant differences in grade 3 and 4 anemia or neutropenia between the two cohorts. There were no differences in increased alanine aminotransferase. Neutropenia was more common in the long zidovudine regimes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our findings provide further evidence of the safety of CNP in infants with high-risk of HIV-1 perinatal transmission.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003297","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:47:22Z","timestamp":1636562842000},"page":"1096-1100","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Safety and Experience With Combined Antiretroviral Prophylaxis in Newborn at High-risk of Perinatal HIV Infection, in a Cohort of Mother Living With HIV-infant Pairs"],"prefix":"10.1097","volume":"40","author":[{"given":"Marta","family":"Ill\u00e1n Ramos","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario Cl\u00ednico San Carlos"},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Cl\u00ednico San Carlos (IdISSC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Soto S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario de Getafe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Mazariegos Orellana","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Cl\u00ednico San Carlos (IdISSC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Manuel","family":"Prieto Tato","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario 12 de Octubre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Guill\u00e9n Mart\u00edn","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario de Getafe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa Luisa","family":"Navarro G\u00f3mez","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital General Universitario Gregorio Mara\u00f1\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"del Rosal Rabes","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario La Paz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Escosa Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario La Paz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Roa Francia","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario de M\u00f3stoles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Beceiro Mosquera","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario Pr\u00edncipe de Asturias"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iciar","family":"Olabarrieta Arnal","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario Severo Ochoa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloy","family":"Mu\u00f1oz G\u00e1lligo","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa Carmen","family":"Vi\u00f1uela Beneitez","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Regidor S\u00e1ez","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Serrano Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Hospital Universitario Cl\u00ednico San Carlos"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arantxa","family":"Berzosa S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Cl\u00ednico San Carlos (IdISSC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Callejas Caballero","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Cl\u00ednico San Carlos (IdISSC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Tom\u00e1s","family":"Ramos Amador","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Universitario Cl\u00ednico San Carlos"},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Cl\u00ednico San Carlos (IdISSC)"},{"name":"Complutense University of Madrid, Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e3282f9b67a","article-title":"Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.","volume":"22","author":"Townsend","year":"2008","journal-title":"AIDS"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/QAD.0b013e32835cffb1","article-title":"Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.","volume":"27","author":"Chiappini","year":"2013","journal-title":"AIDS"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/hiv.12696","article-title":"Severe haematologic toxicity is rare in high risk HIV-exposed infants receiving combination neonatal prophylaxis.","volume":"20","year":"2019","journal-title":"HIV Med"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0213-005X(01)72652-3","article-title":"Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric Association, the National AIDS Plan and the Spanish Gynecology and Obstetrics Society.","volume":"19","author":"Iribarren","year":"2001","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199811123392001","article-title":"Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.","volume":"339","author":"Wade","year":"1998","journal-title":"N Engl J Med"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMoa1108275","article-title":"Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.","volume":"366","author":"Nielsen-Saines","year":"2012","journal-title":"N Engl J Med"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1097\/00002030-200309260-00006","article-title":"Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants.","volume":"17","author":"Le Chenadec","year":"2003","journal-title":"AIDS"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QAI.0b013e318042d5e3","article-title":"Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.","volume":"45","author":"Feiterna-Sperling","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-20250615","first-page":"121","article-title":"Maternal characteristics of a cohort of pregnant women with HIV-1 infection.","volume":"127","author":"Sol\u00eds","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/INF.0b013e31826fe968","article-title":"Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007.","volume":"31","author":"Prieto","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"e0127062","DOI":"10.1371\/journal.pone.0127062","article-title":"Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.","volume":"10","author":"Smith","year":"2015","journal-title":"PLoS One"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1468-1293.2010.00902.x","article-title":"Use of neonatal post-exposure prophylaxis for prevention of mother-to-child HIV transmission in the UK and Ireland, 2001-2008.","volume":"12","author":"Haile-Selassie","year":"2011","journal-title":"HIV Med"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.285.16.2083","article-title":"Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.","volume":"285","author":"Mandelbrot","year":"2001","journal-title":"JAMA"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2393-13-22","article-title":"Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine.","volume":"13","author":"Neubert","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1695-4033(08)75236-6","article-title":"Anaemia and neutropenia in a cohort of non-infected children of HIV-positive mothers.","volume":"69","author":"Fern\u00e1ndez Ibieta","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"20520","DOI":"10.7448\/IAS.19.1.20520","article-title":"Safety of combination antiretroviral prophylaxis in high-risk HIV-exposed newborns: a retrospective review of the Canadian experience.","volume":"19","author":"Kakkar","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/INF.0b013e3181c81fd4","article-title":"Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen.","volume":"29","author":"Lahoz","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1067\/mpd.2003.mpd0335","article-title":"Pharmacokinetics and tolerance of zidovudine in preterm infants.","volume":"142","author":"Capparelli","year":"2003","journal-title":"J Pediatr"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QAI.0000000000001291","article-title":"Nevirapine pharmacokinetics and safety in neonates receiving combination antiretroviral therapy for prevention of vertical HIV transmission.","volume":"74","author":"Lau","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-20250615","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/515641","article-title":"Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team.","volume":"178","author":"Mirochnick","year":"1998","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:06:14Z","timestamp":1750003574000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003297","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,8]]}}}